• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性健康倡议中激素治疗试验中女性性行为的模式和预测因素。

Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.

机构信息

The North American Menopause Society, Mayfield Heights, OH 44221, USA.

出版信息

Menopause. 2011 Nov;18(11):1160-71. doi: 10.1097/gme.0b013e3182227ebd.

DOI:10.1097/gme.0b013e3182227ebd
PMID:21983008
Abstract

OBJECTIVE

The aim of this study was to determine the patterns and predictors of sexual activity in the Hormone Therapy (HT) Trials of the Women's Health Initiative (WHI).

METHODS

Sexual activity questions were administered to 27,347 women ages 50 to 79 years at baseline and at year 1 and to a random 8.6% subsample at years 3 and 6. The associations with demographic and health characteristics were determined.

RESULTS

Sexual activity at baseline was 60.7%, 44.9%, and 28.2% in the 50- to 59-, 60- to 69-, and 70- to 79-year-old age groups, respectively. Most of the participants were satisfied with their current sexual activity (63.2%). Of those dissatisfied, 57% preferred more sexual activity. Vaginal atrophy correlated with sexual inactivity at baseline (P < 0.001). The correlates associated with stopping sexual activity at year 1 included poor/fair self-rated health, lack of satisfaction with quality of life, depression, and loss of partner (P < 0.001). The strongest predictor of sexual activity at year 1 was sexual activity at baseline (odds ratio, 96.71; 95% CI, 81.90-114.20). A subset analysis of women adherent with HT or placebo at years 3 and 6 suggested that HT was associated with a higher percentage of participants reporting sexual activity (P = 0.01).

CONCLUSIONS

Most women in the WHI HT Trials were satisfied with their sexual activity. Of those who were dissatisfied, the majority preferred more, rather than less, sexual activity. Vaginal atrophy at baseline correlated with sexual inactivity, and sexual activity at baseline was the strongest identified predictor of sexual activity at year 1. HT use was not predictive of ongoing sexual activity in the intent-to-treat analysis. This report further characterizes the participants in the WHI HT trials and reveals the complexity of factors related to the prevalence of sexual activity and satisfaction.

摘要

目的

本研究旨在确定妇女健康倡议(WHI)激素治疗(HT)试验中女性性行为的模式和预测因素。

方法

在基线和第 1 年以及第 3 年和第 6 年随机抽取 8.6%的亚组,对 27347 名年龄在 50 至 79 岁的女性进行性行为问题调查。确定与人口统计学和健康特征的关联。

结果

基线时性行为发生率分别为 50-59 岁、60-69 岁和 70-79 岁年龄组的 60.7%、44.9%和 28.2%。大多数参与者对当前的性行为感到满意(63.2%)。其中 57%对性行为不满意的人更希望有更多的性行为。阴道萎缩与基线时的性行为不活跃相关(P < 0.001)。与第 1 年停止性行为相关的因素包括自评健康状况差/一般、对生活质量不满意、抑郁和伴侣丧失(P < 0.001)。第 1 年性行为的最强预测因素是基线时的性行为(优势比,96.71;95%置信区间,81.90-114.20)。对第 3 年和第 6 年坚持服用 HT 或安慰剂的女性进行亚组分析表明,HT 与报告性行为的参与者比例较高相关(P = 0.01)。

结论

WHI HT 试验中的大多数女性对自己的性行为感到满意。在那些不满意的人中,大多数人更喜欢更多的性行为,而不是更少的性行为。基线时的阴道萎缩与性行为不活跃相关,而基线时的性行为是第 1 年性行为的最强预测因素。在意向治疗分析中,HT 使用与持续性行为无关。本报告进一步描述了 WHI HT 试验的参与者,并揭示了与性行为流行率和满意度相关的复杂因素。

相似文献

1
Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.女性健康倡议中激素治疗试验中女性性行为的模式和预测因素。
Menopause. 2011 Nov;18(11):1160-71. doi: 10.1097/gme.0b013e3182227ebd.
2
Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.“女性健康倡议”研究后韩国临床医生对绝经后激素治疗的态度
Menopause. 2006 Jan-Feb;13(1):125-9. doi: 10.1097/01.gme.0000191211.51232.9d.
3
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度:妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
4
The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.妇女健康倡议对医疗补助计划中激素替代疗法的影响。
J Womens Health (Larchmt). 2004 Nov;13(9):986-92. doi: 10.1089/jwh.2004.13.986.
5
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.醋酸甲羟孕酮对雌激素依赖性风险和益处的影响——解读女性健康倡议结果的尝试。
Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.
6
Effects of estrogen plus progestin on health-related quality of life.雌激素加孕激素对健康相关生活质量的影响。
N Engl J Med. 2003 May 8;348(19):1839-54. doi: 10.1056/NEJMoa030311. Epub 2003 Mar 17.
7
A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.低剂量结合雌激素对绝经后女性性功能和生活质量影响的随机研究。
Menopause. 2009 Mar-Apr;16(2):247-56. doi: 10.1097/gme.0b013e318184c440.
8
Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.2000 年以来绝经激素治疗使用模式的变化:柏林 Spandau 纵向健康研究的结果。
Climacteric. 2009 Aug;12(4):329-40. doi: 10.1080/13697130902745120.
9
Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women's Health Initiative in New York City.纽约市女性健康倡议发布后,绝经后女性阴道使用雌激素及其对生活质量和泌尿生殖系统疾病的影响。
Menopause. 2016 Jan;23(1):7-10. doi: 10.1097/GME.0000000000000493.
10
Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).非特异性胸痛女性的心血管风险(来自女性健康倡议激素试验)
Am J Cardiol. 2008 Sep 15;102(6):693-9. doi: 10.1016/j.amjcard.2007.12.044. Epub 2008 Jul 2.

引用本文的文献

1
Sexual health in menopausal women with symptoms of pelvic floor disorders.有盆底功能障碍症状的绝经后女性的性健康
Eur J Midwifery. 2024 Oct 29;8. doi: 10.18332/ejm/194171. eCollection 2024.
2
Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.印度中部绝经后女性外阴阴道萎缩和绝经泌尿生殖综合征及其对生活质量影响的研究
Cureus. 2024 Feb 24;16(2):e54802. doi: 10.7759/cureus.54802. eCollection 2024 Feb.
3
The Role of Sexual Function in Quality of Life Among Midlife and Older Women: The Study of Women's Health Across the Nation.
中年和老年女性生活质量中的性功能作用:全国妇女健康研究。
J Womens Health (Larchmt). 2024 Apr;33(4):426-434. doi: 10.1089/jwh.2023.0439. Epub 2024 Feb 8.
4
Hormone therapy for sexual function in perimenopausal and postmenopausal women.围绝经期和绝经后妇女的性功能激素治疗。
Cochrane Database Syst Rev. 2023 Aug 24;8(8):CD009672. doi: 10.1002/14651858.CD009672.pub3.
5
Cellular and extracellular vaginal changes following murine ovarian removal.卵巢切除后阴道的细胞和细胞外变化。
Physiol Rep. 2023 Aug;11(15):e15762. doi: 10.14814/phy2.15762.
6
Physical characteristics and properties of estradiol softgel vaginal inserts.雌二醇软胶囊阴道插入剂的物理特性和性质。
Menopause. 2020 Feb;27(2):150-155. doi: 10.1097/GME.0000000000001443.
7
Genitourinary Syndrome of Menopause.绝经泌尿生殖综合征
J Midlife Health. 2019 Jul-Sep;10(3):111-113. doi: 10.4103/jmh.JMH_125_19.
8
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.应对女性外阴阴道萎缩(VVA)/绝经泌尿生殖综合征(GSM)以促进健康衰老
Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019.
9
Is Interpersonal Abuse Associated with Sexual (Dis)satisfaction among Postmenopausal Women?人际关系虐待与绝经后妇女的性(不)满意有关吗?
Womens Health Issues. 2019 Jul-Aug;29(4):299-307. doi: 10.1016/j.whi.2019.05.009. Epub 2019 Jul 2.
10
Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials.妇女健康倡议激素治疗试验干预后阶段的性活动与阴道症状
Menopause. 2018 Mar;25(3):252-264. doi: 10.1097/GME.0000000000000994.